Play Earnings CallPlay Earnings Call
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call February 5, 2026 8:30 AM EST
Company Participants
Matt Sims – Vice President of Investor Relations
Jason Hollar – CEO & Director
Aaron Alt – Chief Financial Officer
Conference Call Participants
Erin Wilson Wright – Morgan Stanley, Research Division
Elizabeth Anderson – Evercore ISI Institutional Equities, Research Division
Eric Percher – Nephron Research LLC
Michael Cherny – Leerink Partners LLC, Research Division
Allen Lutz – BofA Securities, Research Division
George Hill – Deutsche Bank AG, Research Division
Kevin Caliendo – UBS Investment Bank, Research Division
Lisa Gill – JPMorgan Chase & Co, Research Division
Daniel Grosslight – Citigroup Inc., Research Division
Glen Santangelo – Barclays Bank PLC, Research Division
Charles Rhyee – TD Cowen, Research Division
Steven Valiquette – Mizuho Securities USA LLC, Research Division
Brian Tanquilut – Jefferies LLC, Research Division
Presentation
Operator
Hello, and welcome to the Second Quarter Fiscal Year 2026 Cardinal Health Inc. Earnings Conference Call. My name is Serge and I will be your coordinator for today’s event. Please note that this conference is being recorded. [Operator Instructions]
I will now hand you over to your host, Matt Sims, Vice President, Investor Relations, to begin today’s conference. Thank you.
Matt Sims
Vice President of Investor Relations
Good morning, and welcome to Cardinal Health’s Second Quarter Fiscal ’26 Earnings Conference Call, and thank you for joining us. With me today are Cardinal Health’s CEO, Jason Hollar; and our CFO, Aaron Alt. You can find this morning’s earnings press release and investor presentation on the Investor Relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide
